Biogen (BIIB, $190.52) was a top loser this quarter, falling -23.78%

A.I.dvisor
at Tickeron.com
04/19/24
Loading...
BIIB - Biogen

Loading...

Price: $190.52
Daily change: -$1.64 (-0.85%)
Daily volume: 1.5M
3-month price change: -$59.44 (-23.78%)
Capitalization: $27.7B
Industry: Pharmaceuticals: Major
Biogen (BIIB, $190.52) was a top loser over the last three months, falling -2 to $190.52 per share. A.I.dvisor analyzed 58 stocks in the Pharmaceuticals: Major Industry for the 3-month period ending April 18, 2024, and found that of them (2) exhibited an Uptrend while of them (7) demonstrated a Downtrend.
View a ticker or compare two or three
BIIBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7570
Web
https://www.biogen.com